MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,389K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of shares...
Accrued expenses
Prepaid expenses
Others
Negative Cash Flow Breakdown
Net income (loss) attributable t...
Payment of notes payable
Stock-based compensation
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss) attributable to parent
-3,730
-3,521
-2,904
-9,246
Amortization of deferred financing costs
8
6
0
18
Change in fair value of convertible notes (issued, converted and outstanding)
-
-
0
0
Change in fair value of liability classified warrants
0
0
0
0
Shares issued for the standby equity purchase agreement commitment fee
0
-
0
298
Stock-based compensation
-99
91
70
290
Accounts receivables
29
-58
16
4
Inventory
20
-9
-17
6
Prepaid expenses
-196
-117
490
-244
Other assets
-78
-79
-78
-80
Accounts payable
31
-229
-1,070
-1,140
Accrued expenses
571
629
221
164
Other liabilities
-
-
0
0
Net cash used in operating activities
-2,994
-2,761
-4,094
-3,844
Proceeds from issuance of convertible notes
-
-
0
0
Payment of convertible notes
-
-
0
0
Proceeds from issuance of shares, net of offering costs
810
329
1,789
9,183
Proceeds from exercise warrants-Convertible Note Warrants
-
-
-
1,818
Proceeds from exercise warrants
0
0
1,813
-
Proceeds of pre-funded warrants
0
0
0
5,886
Proceeds from issuance of notes payable
-
-
767
-
Payment of notes payable
205
200
242
0
Net cash provided by financing activities
605
129
2,311
11,305
Net increase (decrease) in cash
-2,389
-2,632
-1,783
11,944
Cash, beginning of period
9,348
11,980
13,763
1,819
Cash, end of period
6,959
9,348
11,980
13,763
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
shares, net of offering...
$810K
(-84.28%↓ Y/Y)
Net cash provided by
financing activities
$605K
(-94.04%↓ Y/Y)
Canceled cashflow
$205K
Net increase
(decrease) in cash
-$2,389K
Canceled cashflow
$605K
Accrued expenses
$571K
(143.75%↑ Y/Y)
Prepaid expenses
-$196K
(75.00%↑ Y/Y)
Other assets
-$78K
(50.00%↑ Y/Y)
Accounts payable
$31K
(-72.32%↓ Y/Y)
Amortization of deferred
financing costs
$8K
(-55.56%↓ Y/Y)
Payment of notes payable
$205K
(-65.37%↓ Y/Y)
Net cash used in
operating activities
-$2,994K
(47.11%↑ Y/Y)
Canceled cashflow
$884K
Net income (loss)
attributable to parent
-$3,730K
Stock-based compensation
-$99K
(-137.50%↓ Y/Y)
Accounts receivables
$29K
(-72.38%↓ Y/Y)
Inventory
$20K
(-74.03%↓ Y/Y)
Buy us a coffee
SeaStar Medical Holding Corp (ICUCW)
SeaStar Medical Holding Corp (ICUCW)